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Abstract
The identification of stem cells within a mixed population of cells is a major hurdle for stem cell biology–in particular, in the
identification of induced pluripotent stem (iPS) cells during the reprogramming process. Based on the selective expression
of stem cell surface markers, a method to specifically infect stem cells through antibody-conjugated lentiviral particles has
been developed that can deliver both visual markers for live-cell imaging as well as selectable markers to enrich for iPS cells.
Antibodies recognizing SSEA4 and CD24 mediated the selective infection of the iPS cells over the parental human
fibroblasts, allowing for rapid expansion of these cells by puromycin selection. Adaptation of the vector allows for the
selective marking of human embryonic stem (hES) cells for their removal from a population of differentiated cells. This
method has the benefit that it not only identifies stem cells, but that specific genes, including positive and negative
selection markers, regulatory genes or miRNA can be delivered to the targeted stem cells. The ability to specifically target
gene delivery to human pluripotent stem cells has broad applications in tissue engineering and stem cell therapies.
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Introduction
Human embryonic stem cells (hES) and induced pluripotent
stem (iPS) cells are promising resources for gene therapy, drug
screening, and regenerative medicine. However, culturing hES
and iPS cells is a labor-intensive procedure requiring the
enrichment of the pluripotent cells from a heterogeneous
population capable of spontaneous differentiation. For iPS cells,
a major bottleneck is the low efficiency of reprogramming and the
process of identifying and selecting cells reaching the pluripotent
state. For hES applications, the ability to drive differentiation
toward specific pathways through the introduction of limited
factors [1,2] is of high interest. Subsequent removal of undiffer-
entiated hES cells from a differentiated cell population could avoid
the introduction of teratomas into patients. Safe and effective gene
delivery is greatly advanced through targeting binding and content
release via cell-type specific surface markers. This has been
facilitated using lentiviral particles pseudotyped with a modified
Sindbis virus envelope, capable of targeting gene delivery using a
conjugated antibody [3,4]. In this study, this system has been
adapted for viral entry through cell-surface markers expressed on
the hES and iPS cells.
The antibody-directed transduction system utilizes a modified
Sindbis virus envelope, termed m 168, pseudotyped onto lentiviral
particles [3]. The modifications include the replacement of the
laminin binding site with a protein A immunoglobulin G
recognition domain (ZZ domain), and serial mutations to suppress
heparin-binding sites. The insertion of the ZZ domain allows for
targeted viral infection via conjugation with a specific antibody
[5]. A variety of antibody molecules have been developed to be
effective in targeting specific cell types [6–9]. This approach has
been successful in targeting cells within a heterogeneous
population in vitro [9] as well as in vivo, where lung metastatic
melanoma cells were targeted by m 168-pseudotyped lentiviral
particles conjugated with anti-P glycoprotein antibodies through in
vivo tail vein viral injection [3]. In this study we establish an Ab-
mediated transduction system that allows viral entry into hES and
iPS cells mediated by antibodies recognizing either the SSEA4 or
CD24 surface molecules.
Embryo-derived hES cells offer great hope for their use in
therapeutic treatment of various diseases, however ethical
concerns regarding these cells remain. Recently, pioneering work
indicates that the ectopic expression of transcriptional factors
including Oct4, Sox2, Klf4, cMyc, Lin28, and Nanog could
reprogram human somatic cells into iPS cells [10–15]. During the
reprogramming process, fully reprogrammed iPS cell colonies
emerge among a large and heterogeneous background population
of fibroblasts and incompletely reprogrammed cells. At present,
isolation of iPS cells from the heterogeneous population relies on
manual selection of colonies via morphological criteria and live-
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delivering reporter genes into human iPS cells through the Ab-
directed targeted transduction system during reprogramming of
somatic fibroblast cells to the pluripotent state. The successfully
reprogrammed iPS cells can be specifically infected by the
targeting Ab, marked by enhanced green fluorescent protein
(eGFP), and enriched under puromycin selection. This provides a
relatively easy tool for monitoring and identifying potential iPS
cells, as well as hES cells within a mixed heterogeneous
population.
Results
Optimization of gene transduction using VSV-G
pseudotyped lentiviral vectors on the H9 human ES cell
line
Poor viral transgene expression in hES cells is a well-known
phenomenon. Conditions were optimized to increase viral
infection and expression in the undifferentiated and differentiated
hES cells (see Text S1, Fig. S1 and Fig. 1). Maximal viral
transduction was obtained when hES cells were dispersed into
single cells with Accutase followed by the addition of the ROCK
inhibitor Y-27632 [17] to protect cells from apoptosis and
increases colony formation (Fig. S1). Variation in the lentiviral
vector backbone can also contribute to efficiency of gene transfer
and cell expression profiles. Two vectors were compared for
expression of eGFP: pHR’CMVGFPW expressed GFP from an
internal cytomegalovirus (CMV) immediate-early promoter and
pSin-EF2-GFP-Puro expressed GFP from the elongation factor-1
a (EF1a) promoter. Virus bearing both vectors delivered and
expressed high levels of GFP into 293T cells (.97% of cells
infected; data not shown). In our experimental system, a vector
was desired which efficiently expressed GFP in both undifferen-
tiated H9 stem cells as well as BMP4 induced trophoblasts. Fig. 1
compares the eGFP expression from pSin-EF2-GFP-Puro (EF1a
promoter) and the pHR’CMVGFPW (CMV promoter) by flow
cytometric analysis (panel A) and fluorescence microscopy (pa-
nel B) after gene transduction by lentiviral particles pseudotyped
with the non-selective VSV-G Env during BMP4 driven
trophoblast differentiation of hES H9 cells [18]. The pSin-EF2-
GFP-Puro (EF1a promoter) provided maximal GFP expression in
both the undifferentiated cells as well as the day 10 differentiated
cells with greater than 95% of the cells expressing GFP. In
contrast, the pHR’CMVGFPW (CMV promoter) was silenced in
the undifferentiated H9 stem cells (4.0% GFP
+) but active in the
differentiated trophoblast cells (49% GFP
+). Identical results were
observed using fluorescence microscopy (Panel B) as with flow
cytometry (Panel A). Constructs expressing eGFP from the pSin-
EF2-GFP-Puro based vector were used in subsequent studies.
Specific gene delivery to hES cells via antibody-
conjugated m 168 pseudotyped lentiviral vectors
A key bottleneck in many stem cell applications is the ability to
identify, select or counterselect for the stem cells within the mixed
population. Specific gene delivery has been achieved using
antibody-conjugated systems, in particular lentiviral particles
pseudotyped with a modified Sindbis Env (m 168), encoding a
protein A immunoglobulin G recognition domain (ZZ domain)
[5]. In order to investigate whether the m 168 pseudotyped
lentiviral vectors were able to deliver the eGFP gene into the hES
cell via a specific monoclonal antibody, we tested a panel of
antibodies recognizing hES cell surface marker proteins, including
SSEA4, CD24, SSEA3, FZD7, and CD9 (Fig. 2) [19–21]. Cell
surface expression of all the markers were readily detected on the
H9 cells by flow cytometry (Fig. S2: SSEA3 (93.0%+), SSEA4
(92.3%+), CD24 (99.6%+), FZD7 (77.8%+), CD9 (91.6%+), and
HLA-1 (86.4%+)). Transduction efficiency was determined by
measuring eGFP gene transfer into hES H9 cells. The results
indicate that anti-SSEA4 (Fig. 2, panel a, 86% eGFP
+), anti-
CD24 (Fig. 2, panel b, 66% eGFP
+), and anti-CD9 antibodies
(Fig. 2d, 79% eGFP
+) conjugated with lentiviral particles
pseudotyped with m 168 were able to transduce hES cells. As a
control, eGFP delivery in VSV-G-pseudotyped lentivirus was at a
level of 93%. Control infection using an IgG k2 isotype antibody
resulted in transduction levels equivalent to the no antibody
controls, indicating the absence of background from nonspecific
transduction of igG antibodies (data not shown). Surprisingly, no
transduction was observed using the FZD7 IgG antibody, despite
being expressed on the surface of H9 cells (Fig. S2), indicating that
not every cell surface protein can serve as an effective receptor for
the antibody-mediated transduction [22,23]. Binding to a receptor
is the first step of viral entry leading to a complex series of
conformational changes required for membrane fusion and viral
content release into the cellular cytoplasm, either at the cell surface
or during transport through the cellular endosomal pathways.
Variations in the endocytosis and recycling of the cell surface
receptors therefore can greatly influence the efficiency of the
targeted transduction. Transduction using lentiviral particles
conjugated with HLA-1 [3,9] was 47% eGFP
+ (Fig. 2e).
Antibody binding to the ZZ domain is limited predominantly to
IgG molecules. Three of the most frequent used antibodies to
identify human embryonic stem cells, anti-SSEA3, TRA-1-60 and
TRA-1-81, though are IgM molecules and are predicted not to
associate with the ZZ domain [24]. Experimentally, the SSEA3
IgM antibody was not effective in targeting entry, yielding eGFP
transduction equivalent to the no antibody control (Fig. 2,
panels f, g). A strategy to bridge the SSEA3-IgM complex to the
m 168 pseudotyped viral particle via an IgG anti-IgM antibody
has failed to rescue targeting (data not shown), indicating a spatial
or steric requirement for this targeting strategy.
To further define the specificity, the SSEA4, CD9, CD24, and
HLA-1 antibody-mediated transduction using the m 168 pseudo-
typed lentiviral particles was tested on alternative cell lines. Of
critical interest was the ability to recognize human iPS cells, which
have been shown to express similar markers as embryonic stem
cells. In addition, human foreskin fibroblasts (HFF) and AG1
primary fibroblast (data not shown) were tested as target cells, as
fibroblasts are a key source of cells for reprogramming protocols.
Using the iPS5 cells line (from Dr. George Q. Daley lab) [14], the
transduction efficiency paralleled that of human hES cells for all
antibodies tested. Quite significantly, the virus conjugated with the
SSEA4 and CD24 antibodies discriminated hES H9 and iPS cells
from the differentiated HFF, with an average of 78% and 70% of
the hES H9 and iPS cells, respectively, eGFP
+ after infection in the
presence of the CD24 antibody, compared with 1.2% of the cells
eGFP
+ on the HFF (Table 1). The results for the primary
fibroblasts AG1 mirrored that of the HFF (data not shown). This
differential for infection of hES and iPS cells over fibroblasts was
not observed with the CD9 [20] or the general HLA-1 antibody.
Thus, gene delivery using the CD24 and SSEA4 antibody-
conjugated targeting provides the specificity to infect the hES and
iPS cells over fibroblast. All cells positive for infection showed
.86% cell surface expression of the marker protein (CD24,
SSEA4, HLA-1 and CD9) by flow cytometry. HFF displayed
extremely low cell surface expression for SSEA4 (average 3.3%)
and CD24 (2.5%).
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mixed cell population monitored by flow cytometry
This differential infection of stem versus differentiated cells was
examined within a heterogeneous population, to test whether this
method could identify and differentially mark stem cells for specific
applications. hES H9 cells and HFF cells were mixed at different
ratios and infected by m 168-pseudotyped lentiviral particles
conjugated with anti-SSEA4 or anti-CD24 antibodies. Fig. 3, left
shows the bright field and fluorescence images of the population
mixed at 1:9 ratio of hES H9: HFF cells. For cells infected with the
CD24 antibody-conjugated lentiviral particles, GFP expression
clustered within cells with the H9 stem cell morphology (panel b).
Anti SSEA4 antibodies similarly delivered GFP to H9 cells
(panel d), but a background (,10%, Table 1) of GFP
+ fibroblast
can be observed. The eGFP transduction efficiency was evaluated
5 days post-infection by flow cytometry (Fig. 3, right). The level of
hES H9 cells within the mixed population was confirmed by flow
cytometry using mouse anti-CD24 Ab/a-mouse IgG conjugated
with PE. There was a direct correlation of the level of eGFP
positive cells transduced through the CD24 Ab-viral conjugated
with the percentage of hES H9 cells in the mixed population. In
these experiments, maximal antibody-mediated GFP gene delivery
corresponded to 58% of the H9 cells (Fig. 3, right, 100% H9
cells). These results indicate the lentiviral eGFP gene transduction
in the presence of anti-CD24 antibody can specifically label hES
within a hES H9 cell/HFF mixed population.
Figure 1. pHR’CMVGFPW (CMV?eGFP? and pSin-EF2-GFP-Puro (EF1a?eGFP?show distinct expressing levels in hES H9 cells and
trophoblasts. Trophoblasts were induced from H9 cells by MEF conditioned medium with 20 ng/mL human recombinant BMP4 for 10 days. eGFP.
Panel A) Flow cytometry of GFP
+ cells; Panel B, fluorescence microscopy (1006magnification, scale bar=100 mm).
doi:10.1371/journal.pone.0034778.g001
Figure 2. Analysis of antibodies capable of delivering m 168-pseudotyped lentiviral particles into human H9 cells. m 168-
pseudotyped lentiviral particles packaging the EF1a-eGFP cassette were incubated with the individual antibodies labeled above each panel and used
for infection of human H9 cells. Expression of GFP in H9 cells was analyzed by flow cytometry. Panel a, Anti-SSEA4; Panel b, Anti-CD24; Panel c, Anti-
FZD7; Panel d, Anti-CD9; Panel e, Anti-HLA 1; Panel g, Anti-SSEA3; Panel g, No antibody control. In parallel, eGFP delivered by VSV-G-pseudotyped
lentivirus was used as a positive control (Panel h).
doi:10.1371/journal.pone.0034778.g002
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reprogramming utilizing anti-CD24 Ab-mediated
selective transduction
The antibody-mediated gene delivery into cells expressing stem
cell markers would be invaluable for the identification of iPS cells
during the reprogramming process. The ability of the m 168-
pseudotyped lentiviral particles to selectively infect stem cell during
reprogramming of human somatic cells to iPS cells was assessed
(for timeline, Fig. 4 top left). Studies were initiated to generate
human iPS from African-American human primary fibroblasts by
infected with M-MuLV-based retroviral vectors (pMXs) encoding
the four defined human transcription factors Klf4, Oct4, Sox2,
and c-Myc [12]. In addition, the pMXs-Nanog vector, encoding
the monomeric transcription factor Nanog, was included in order
to increase the iPS induction efficiency [15]. eGFP-IRES-Puro
gene was delivered to iPS cells by anti-CD24 Ab conjugated with
m 168-pseudotyped lentivirus 21 days post-induction. By 4 weeks
of induction, hES-like colonies (small condensed cells) with low
retention of Hoechst dye (Hoechst
dim) [16,25] characteristic of
undifferentiated human embryonic stem cells were detected
expressing both eGFP and TRA-1-60 (Fig. 4 a–d). Antibody
mediated infection of a preformed colony in the absence of
mechanical or enzymatic disruption occurs in a localized patch
within the colony, visible by intense GFP staining (Fig. 4 and
Fig. S1). Tra-1-60 live staining of the colony using DyLight
TM 488
conjugated antibodies indicate a low-level of green labeling of the
colony overlapping the GFP+ cells. Dual labeling of eGFP and
TRA-1-60 was not observed in cells lacking hES-like morpholo-
gies. At 30 days post-induction, colonies were passaged onto
puromycin resistance MEF feeder cells and selected by puromycin.
After one week of puromycin selection, Puro
R iPS colonies were
observed which were also enriched for eGFP expression.
Puro
R iPS colonies were characterized for their stem cell
qualities using multiple assays. Initially, individual GFP
+ colonies
were analyzed for expression of endogenous pluripotent stem cell
markers including TRA-1-60, TRA-1-81, SSEA3, SSEA4 and
CD24 by immunofluorescence staining and revealed uniform co-
expression (Fig. 4 e–n). Cells were also positive for alkaline
phosphatase (data not shown). Negative control of a-mouse IgG
PE conjugated secondary antibody is shown (Fig. 4 o, p); identical
results with a-mouse and a-rat IgM Alexa Fluor 594 secondary
Abs were obtained (data not shown).
Additional studies analyzed the mRNA levels of endogenous
pluripotent makers including Oct4, Nanog, Sox2, ABCG2,
DNMT3B, Rex1, and hTERT in five independent iPS cell lines
of African American descent selected by the CD24-antibody
complexed to m 168 pseudotyped lentiviral particles and puro-
mycin selection (Fig. 5). Expression at levels similar to hES H9
embryonic stem cells was detected in the five iPS cells lines. These
products were not expressed in the parental primary fibroblasts
used to generate the iPS cells (Fig. 5, panel A, lane F). A lower
level of hTERT was observed in three of the lines (iPS G2, G3 and
G6) and telomerase activity was therefore directly measured in
these cell lines using the Telomerase Repeat Amplification
Protocol (TRAP) assay (Fig. 5, Panel B). iPS G1 with high level
of hTERT expression was included as a control for comparison
Table 1. Antibody-specific transduction of stem and
differentiated cells.
Antibody Cell line
hES H9
a iPS5
a HFF
a
No Ab 5.4+/23.1 6.9+/22.1 1.6+/20.47
Anti-SSEA4 73+/213 80+/241 0 +/22.1
Anti-CD24 78+/212 70+/29 1.2+/20.15
Anti-CD9 71+/286 8 +/26.2 73+/222
Anti-HLA-1 45+/225 1 +/21.1 67+/223
aPercentage GFP
+ cells was determined by flow cytometry after m 168
pseudotyped lentiviral infection. Results are average of 2–3 infections, with
average deviations indicated.
doi:10.1371/journal.pone.0034778.t001
Figure 3. Anti-CD24 and anti-SSEA4 targeted transduction of m 168-pseudotyped virus in a mixed population of hES/HFF cells. Left:
Analysis of m 168-pseudotyped viral conjugating with anti-CD24 (left Panels a, b) or anti-SSEA4 (left Panels c, d) into a population of hES H9 cells
mixed with HFF at a ratio of 1:9. Panels a and c, bright field microscopy (406magnification). Clusters of H9 cells are outlined in red. Panels b and d,
fluorescence image of cells expressing GFP (406magnification). Right panel: eGFP gene transfer by anti-CD24 conjugated viral particles was analyzed
on 5 days post-infection by flow cytometry. hES H9 cells and HFF cells were mixed at different ratios (indicated above each panel). Analysis of the hES
H9 cells within the population was confirmed by using mouse a-CD24 Ab/a-mouse IgG conjugated with PE. Scale bar=100 mm.
doi:10.1371/journal.pone.0034778.g003
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activity, as judged by the presence of the telomerase repeat
products of increasing size was observed in the iPS G1, G2, G3,
and G6 cell lines at levels equal or greater than that observed in
the hES H9 cells. No telomerase products were detected in the
fibroblast control cells. The iPS cell lines were also examined for
their ability to differentiate into embyroid bodies and express
markers for the three cell lineages (Fig. 6). The expression of
markers for the endoderm (AFP and GATA4), ectoderm (FoxA2
and PAX6), and mesoderm (BRACHYURY and COL1A1) using
RT-PCR was compared in embryoid bodies (EB) formed from the
five iPS cell lines as well as from hES H9 cells. Markers for all
three lineages were detected in the EB, which were not present in
the undifferentiated H9 cells. We conclude that anti-CD24
antibody mediated selective transduction is effective tool for
labeling, selecting and isolating cells with iPS characteristics during
reprogramming of fibroblasts.
Figure 4. Anti-CD24 directed targeting in reprogramming human iPS cells. Schematic of iPS cell induction, marking and isolation (Top, left).
Human primary fibroblasts were infected with pMXs vectors encoding the defined transcriptional factors (Oct4, Sox2, Klf4, c-Myc. Nanog). The cell
was then targeted with the anti-CD24 Ab conjugated with m 168-pseudotyped lentivirus 21 days post-induction. Panel a shows the bright field of a
putative iPS colony 30 days post-induction. The lentiviral transduced GFP
+ colonies (Panel b) displayed Hoechst
dim (Panel c) and were Tra-1-60
positive (Panel d) in live-staining using DyLight
TM 488 conjugated mouse anti-human Tra-1-60. Panels a–d, 406 magnification. Panels e–p, 1006
magnification. iPS cells were passaged to Mitomycin treated-
PuroRMEF feeder cells and selected with puromycin. The selected GFP
+ iPS colonies
(panels e, g, i, k, m, and o) were validated by immunofluorescence staining with Tra-1-60 (Panel f), Tra-1-80 (Panel h), SSEA3 (Panel j), SSEA4 (Panel l)
and CD24 (Panel n) using anti-mouse IgG PE conjugated secondary antibodies (Panel l, n) or corresponding Alexa Fluor Series secondary antibodies
(Panel f, h, j). Panel p- anti-mouse IgG PE conjugated secondary antibody control (omit primary antibody). Scale bars=100 mm.
doi:10.1371/journal.pone.0034778.g004
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The use of the antibody-targeted gene delivery to stem cells
offers additional applications for stem cell differentiation protocols.
Lentiviral vectors can be used to deliver tissue-specific genes to
promote differentiation towards a specific pathway. Alternatively,
within any differentiation process, the persistence of undifferen-
tiated stem cells is also a major concern as they can seed teratomas
in transplantation recipients. With this goal, the lentiviral vector
has been modified to deliver the HSV TK gene, allowing for
selective killing of the undifferentiated stem cells in the presence of
ganciclovir [26]. Fig. 7 outlines the vector (pSin-EF2-TK-Puro),
with TK driven by the EF1a promoter. hES H9 cells were treated
with BMP4 [18], allowing for trophoblast differentiation. Cells
were infected with either the SSEA4 or CD24 antibody
conjugated m 168 pseudotyped virus bearing the pSin-EF2-TK-
Puro lentiviral vector, five days post BMP4 addition and counter-
selected with 2 mM ganciclovir. Trophoblast formation was
monitored for expression of cytokeratin 7, a marker of both
villous and extravillous trophoblasts by flow cytometry ten days
post BMP4 addition [27–29]. The percent cells expressing
cytokeratin 7 increased as a result of ablation of the cells
expressing the TK gene through either the CD24 or SSEA4
antibody mediated m 168 lentiviral gene delivery. In the absence
of treatment with Ab-targeting virus, 9.9% of the cells differen-
tiated to express cytokeratin 7. In contrast, Ab-targeting through
the CD24 or SSEA4 markers with TK+ virus followed by
ganciclovir ablation, resulted in 30% and 27% of the cells,
respectively, cytokeratin 7 positive. Further analysis of the
differentiated cell population indicated the loss of cells expressing
high levels of ABCG2, responsible for the (Hoechst
dim) phenotype
characteristic of hES cells [16,25], proportional to the enrichment
observed for cytokeratin 7 positive cells (data not shown).
Ganciclovir treatment, in the absence of the TK gene, resulted
in a minor decrease of cytokeratin 7+ cells (data not shown),
supporting that the enrichment of cytokeratin 7+ cells observed
was a result of the loss of TK+ undifferentiated cells.
Discussion
The undifferentiated state of human ES cells is often
characterized by the expression of the cell surface antigens. There
are several distinct surface markers expressed on undifferentiated
human ES cells, including SSEA4 [30], SSEA3 [31], TRA-1-60,
and TRA-1-81 [32]. In addition, CD24, FZD7, and CD9 are also
putative human stem cell markers [19,21]. In this study, we
examined the ability of these specific Abs to selectively deliver
genes to undifferentiated human ES cell by using the m 168
Sindbis Env antibody bridging system. On the basis of our results,
we have demonstrated that lentiviral particles pseudotyped with
modified Sindbis virus Envelopes (m 168) containing the immu-
noglobulin Fc-binding domain were able to target the hES cells
and human iPS cells via anti-SSEA4 and anti-CD24 antibodies at
a high transduction level with bias for the pluripotent stem cell
over fibroblasts. The development of this technology has shown
great enrichment of the pluripotent stem cells, enabling rapid and
large-scale generation of iPS cells.
Although SSEA4 is a stem cell marker, CD24 is expressed on
keratinocytes, mature granulocytes and in many B cells [19,33] in
addition to pluripotent stem cells. For the purpose of identifying
iPS cells from skin fibroblasts, this is not a concern because the
level of expression on the parental fibroblasts is not significant and
thus the induction of CD24 expression on the stem cell is a valid
marker for reprogramming. However, if the parental cells used for
reprogramming is different, the level of expression of CD24 within
this population would need to be verified in order to use this
protocol to select for iPS cells.
Tissue specific gene delivery can be achieved through both the
viral entry pathway and transcription regulation via specific
Figure 5. Characterization of endogenous pluripotent makers
in selected iPS cell lines. Panel A. Total RNA was isolated using
RNeasy Micro Kit from selected iPS cell lines (G1–G3, G5, G6), hES H9
cells (H9), and human primary fibroblasts (F). Total RNA (500 ng) was
reverse-transcribed using Superscript III Reverse Transcriptase primed
with oligo(dT)12–18 and used as template in subsequent PCR with Taq
DNA Polymerase. PCR analysis examined the expression of endogenous
Oct4, Nanog, Sox2, as well as ABCG2, Rex1, DNMT3B and hTERT. GAPDH
was used as an internal control. N, no template control (N). PCR
products were analyzed on a 10% polyacrylamide TBE Precast Gel.
Panel B. TRAP assay for telomerase activity. Selected iPS cells (G1–G3,
G6), hES H9 cells (H9), and human primary fibroblasts (F) were analyzed
for telomerase activity using the TRAPEZE RT Telomerase Detection Kit
as described in M&M. PCR products were separated on 10%
polyacrylamide TBE Precast Gel. Individual samples are as indicated.
doi:10.1371/journal.pone.0034778.g005
Figure 6. Embryoid Body. EBs from selected iPS cell lines (G1–G3, G5,
G6) and hES H9 cells (H9) were harvested 10 days post-differentiation
and total RNA (500 ng) was reverse-transcribed and used as template in
subsequent PCR reactions. PCR analysis examined the expression of
endogenous AFP, GATA (Endoderm), FoxA2, PAX6y (Ectoderm),
BRACHYURY, and COL1A1 (Mesoderm). GAPDH was used as an internal
control. N, no template control. PCR products were analyzed on a 10%
polyacrylamide TBE Precast Gel.
doi:10.1371/journal.pone.0034778.g006
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of the pseudotyped lentiviral particles, utilizing the EF1a promoter
because of its general high level of expression in both the
differentiated and undifferentiated cells from hES cultures.
Additional layers of selection can be incorporated into this system
through the use of stem cell specific promoters. Alternatively,
lentiviral vectors in which the reported gene is linked with stage-
specific miRNAs have recently been reported to allow for
monitoring the reprogramming state of HFF [34]. Combining
these transcription/post-transcription systems with the targeted
entry would increase the specificity in defining iPS cells in a
heterogeneous live cell culture.
The ability to select for the SSEA4 or CD24-targeted cells with
puromycin does provide an advantage to enrich and amplify the
reprogrammed cells, especially if the efficiency of iPS formation is
low. Thus, this provides an alternative to live staining with TRA-1-
81 and TRA-1-60 antibodies [15,16]. It should be noted that the
cells transduced within the iPS colony are not characteristically
distinct from the other cells, but rather reflects the ability of the
virus to infect a pre-formed colony. Morphological selection of
putative iPS colonies remains a criteria for passage of cells, and
thus distinguishes them from the nonspecific background. In
addition, the anti-SSEA4 and anti-CD24 antibody conjugated
m 168-pseudotyped lentivirus can discriminate hES cells from
mouse embryonic fibroblast (MEF) feeder cells and thus avoid
gene delivery into the support cells, if the hES cell lines are
cultured on MEF feeder cells. The approach also has the potential
to deliver reprogramming factors that may be limiting, allowing
for the conversion of reprogramming intermediates to true iPS
colonies during the selection process [16].
The use of lentiviral pseudotyped viruses do result in an
integrated copy of the transfer vector, and the vectors can be
adapted to include the cre/lox system to allow for subsequent
excision. However, for specific applications, such as the removal of
the marked stem cell population from the differentiated popula-
tion, this is not a concern. For every system, the shortfalls are
countered by their benefits. The use of the antibody-conjugated
m 168 pseudotyped virus has the potential to both improve the
selection and identification of iPS cells, leading to insights into
their reprogramming, as well as the studies of hES cells, where
delivery of regulatory proteins and selectable markers can improve
the homogeneity of the pathways of interest.
Materials and Methods
Cell culture
Human H9 ES cell line (WA09) was from the WiCell Research
Institute (Wisconsin, USA). iPS5 cells were a gift from Dr. George
Q. Daley [14]. hES and iPS5 cell lines were maintained in feeder-
free cultures on Matrigel-coated six-well plates (BD Biosciences)
with mTeSR
TM1 (StemCell Technologies Inc). For regular
passage, hES cells were treated with 1 mg/mL of dispase for
5 min, collected with a cell scraper and plated. For virus
transduction, cells were treated with 1 mg/mL Accutase for 5–
10 min until the colonies were dissociated into single cells. The
single-cell colonies were then detached and plated with
mTeSR
TM1 containing 5 mM ROCK-inhibitor Y27632 [17] for
24 hr. HEK293T cells purchased from American Type Culture
Collection (ATCC; Manassas, VA) and maintained in Dulbecco’s
modified Eagle medium (DMEM; Gibco) containing 10% fetal
bovine serum (FBS; Atlanta Biologicals) and antibiotics &
antimycotics (Gibco).
Plasmids construction
Two vectors were utilized that encoded either the cytomega-
lovirus (CMV) promoter or the human elongation factor-1a
(EF1a) promoter to drive the GFP expression. The CMV-GFP
expression vector, pHR’CMVGFPW, was kindly provided by Dr.
J. Dougherty (UMDNJ). pSin-EF2-Oct4-Puro (Addgene), encod-
ing the EF1apromoter was modified to express either GFP (pSIN-
Figure 7. Selective ablation of undifferentiated cells during in vitro differentiation. Panel a. Schematic of pSin-EF2-TK-Puro vector and
timeline of trophoblast differentiation and selection. hES H9 cells were induced to trophoblasts by culturing in MEF condition medium with 20 ng/mL
human recombinant BMP4. m 168 pseudotyped lentiviral particles packaging the pSin-EF2-TK-Puro vector delivered the TK gene into the
undifferentiated cells via CD24 or SSEA4 conjugated antibodies five days post BMP4 addition and maintained in 2 mM ganciclovir. Panel b.
Trophoblast formation was monitored by flow cytometry for the expression of cytokeratin 7 ten days post BMP4 addition.
doi:10.1371/journal.pone.0034778.g007
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(TK) cassettes (pSin-EF2-TK-Puro) through replacement of the
Oct4 gene from SpeI to EcoR1. The GFP gene was amplified
using pGIP [35] as template with the following primers: EF1a-
GFP fwd, 59-GCA CTA GTG CCA CCA TGG TGA GCA AGG
GCG AG -39; EF1a-GFP rev, 59-GGC GAA TTC TTA CTT
GTA CAG CTC GTC CAT GCC -39. The TK gene was
amplified from the template pAL120-TK (Addgene) using the
primers EF1a-TK fwd, 59- AGC ACT AGT GCC ACC ATG
GCT TCG TAC CCCTGC-39 and EF1a-TK rev, 59-GGC
GAATTC TCA GTT AGC CTC CCC CAT CTC -39. The SpeI
and EcoRI restriction sites are underlined. All of the constructs
were verified by DNA sequencing.
The chimeric Sindbis viral envelope vector m 168 was a gift
from Dr. I. Chen (UCLA) [3]. The HIV-1 packaging vector
pCMV-dR8.2dvpr was purchased from Addgene. The plasmid
pHIT-G [36] expresses VSV-G.
Lentiviral production and transduction
All lentiviral particles were produced by co-transfecting
HEK293T cells using Fugene6 (Roche). HEK 293T cells was
cultured in DMEM containing 10% ultra-low IgG FBS (Gibco)
during the transfection. Briefly, a mixture of 2 mg HIV-based
lentiviral expression vector, 2 mg pCMV-dR8.2 dvpr, and 2 mg
m 168 vector or pHIT-G, complexed with 18 mL Fugene 6 in
1 mL Dulbecco’s modified Eagle medium was added to HEK
293T cells in a 10-cm plate. Supernatants were collected 48 hr
post-transfection, filtered through a 0.45 mm pore-size filter and
stored at 280uC. Multiplicity of infection was calculated based on
the titer of m 168 pseudotyped particles in the presence of the
HLA-1 Ab on 293T cells.
H9 cells, iPS cells, HEK 293T, and human foreskin fibroblast
cells (2610
4 cells) were infected by m 168-pseudotyped lentiviral
particles at a MOI of 5 and conjugated with different antibodies
(1 mg/mL) for 24 hr. In parallel, cell lines were infected with VSV-
G-pseudotyped lentiviral particles as a positive control. The
transduction efficiency was detected by the eGFP expression in the
target cells using flow cytometry 9 days after infection. Flow
cytometry was performed at Rutgers/UMDNJ FACS Core
Facility with Beckman Coulter Cytomics FC500 and analyzed
using CXP Software.
Isolation of African-American primary fibroblast cells
The human primary fibroblast cells were prepared as previous
reports [37]. The skin punch biopsies were obtained from
Cooperative Human Tissue Network, Univ. of Pennsylvania
Medical Center. The skin biopsies were washed in DMEM/F12
and minced into approximately 0.5–1-mm size pieces before being
seeded onto gelatin-coated 6-well cell culture plates containing
mouse embryonic fibroblast (MEF) media consisting of Dulbecco’s
modified Eagle medium: Nutrient Mixture F-12 (DMEM/F12;
Gibco) containing 10% fetal bovine serum (FBS; Atlanta
Biologicals) and antibiotics & antimycotics (Gibco).
The culture medium was partially changed every two days.
Once the dense outgrowths of fibroblast were expanded to 80–
90% confluence (Passage 0; usually day 19–21), the attached
biopsy fragments and the fibroblasts were harvested through brief
exposure to 0.05% trypsin-EDTA (Invitrogen) and passed through
a 70-mm cell strainer to remove large chunks of tissue. These
fibroblast cells were cultured until they reached 90% confluence
and then frozen in FBS supplemented with 10% dimethyl
sulphoxide (DMSO, Sigma-Aldrich) (Passage 1).
Human iPS cells generation
Human iPS cells were induced by retroviral particles which
were produced by co-transfection of the retroviral pMXs vector
individually expressing the five transcription factors, including
Oct4, Sox2, c-Myc, Nanog, and Klf4 (Addgene) (2 mg) plus the
VSV-G envelope vector (2 mg) into TECeB cells [38] by using
Fugene (Roche), as recommended by the manufacturer. Viral
supernatants were harvested 2 days later, concentrated by Retro-
X concentrator (Clontech), resuspended by 5 mL DMEM/F12
with 10% FBS, L-glutamine, 8 mg/mL polybrene (Sigma, H9268),
and antibiotic-antimyotic mixture. The virus was used to infect 10
5
primary fibroblast cells for 24 hours. Seven days post-induction,
cells were passaged onto gelatin coated plates which contain
mitomycin-treated MEFs cells in iPS reprogramming medium
consisting of DMEM/F12 supplemented with 1 mM L-glutamine,
0.1 mM nonessential amino acids, antibiotic-antimyotic, 20%
knockout serum replacement (Invitrogen), 0.1 mM b-mercapto-
ethanol, and 10 ng/ml basic FGF (Stemgent) as previously
described [12]. For m 168 Ab-mediated lentivirus transduction,
puro
R-MEF was purchased from StemGent.
Monoclonal antibodies (mAbs)
Ab-mediated targeting transduction experiments and iPS
immunofluorescence staining were performed using the following
primary antibodies: Mouse anti-human HLA ABC (Sigma, HLA
class I, clone W6/32), anti-SSEA4 (Millipore, MC-813-70), anti-
CD9 (Millipore, MM2/57), anti-CD24 (AnaSpec, ML5), TRA-1-
60 (Millipore), and TRA-1-81 (Millipore), rat anti-human FZD7
(R&D system, 151143), anti-SSEA3 (Millipore, MC-631). Second-
ary antibodies used were goat anti-mouse IgG-R-phycoerythrin
antibody from Sigma (1:500), Goat anti-Rat IgG – FITC
conjugate, and Alexa Fluor 488 goat anti-rat IgM antibody from
Invitrogen. The DyLight
TM 488 mouse anti-Human TRA-1-60
antibody (Stemgent) (1 mg/mL) was used for live cell staining of
the reprogramming cells by incubating for 30 minutes at 37uC and
5% CO2 in the iPS reprogramming medium. Cells were then
washed 2 times with iPS reprogramming media and images were
obtained on a Nikon Eclipse Ti microscope.
Trophoblast differentiation and TK negative selection
Before differentiation, 2610
4 cell hES H9 cells were treated
with Accutase and plated in one Matrigel-coated six-well plate
with mTeSR
TM containing 5 mM ROCK-inhibitor Y27632. After
24 hr, media was replaced with MEF conditioned medium plus
20 ng/mL BMP4 (Sigma) and changed daily. Five days post
BMP4 addition, cells were infected with either the SSEA4 or
CD24 antibody conjugated m 168 pseudotyped virus bearing the
pSin-EF2-TK-Puro (EF1a-TK) lentiviral vector for 24 hours. The
infected cells were cultured in MEF conditioned media (CM)
medium with BMP4 plus 2 mM ganciclovir (Sigma) from day 7 to
day 10. After 4 days selection in ganciclovir, cells were treated
with trypsin/EDTA solution, fixed in 2% paraformaldehyde, and
permeabilized by suspension in PBS containing 0.1% Triton X-
100. 5610
5 cells (100 ml of the cell suspension) were mixed with
1 ml of mouse anti-human Cytokeratin 7 antibody (5 mg/ml)
(Abcam, RCK105). Secondary antibodies used were goat anti-
mouse IgG-R-phycoerythrin antibody from Sigma (1:500). The
samples were analyzed on a FACS Calibur flow cytometer.
RT-PCR and PCR
Total RNA was harvested using RNeasy Micro Kit (Qiagen)
and quantified by spectrophotometer. 500 ng of RNA was used for
cDNA synthesis using Superscript III Reverse Transcriptase
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Taq DNA Polymerase (NEB). Primer sequences were the same as
previously described [16].
TRAP Assay
TRAP Assay was performed by using TRAPEZEH RT
Telomerase Detection Kit (S7710 Millipore) with Taq polymerase
(NEB), according to the manufacturer’s instructions. 500 cells
were extracted by CHAPS lysis buffer (S7710 Millipore), extracts
were analyzed by PCR with Taq DNA Polymerase and separated
by 10% polyacrylamide TBE Precast Gel (Bio-Rad).
EB formation
Human iPS cells were harvested by cell scraper and plated on
Ultra low adhesion plate (STEMCELL Technologies) in DMEM/
F12 (Gibco) consisting of 15% fetal bovine serum (FBS; Atlanta
Biologicals), 15% knockout serum replacement (Invitrogen),
0.1 mM nonessential amino acids and 0.5% penicillin and
streptomycin. Media was changed every two day. Ten days post-
differentiation, EBs in the supernatant were harvested by
centrifugation (BeckmanAllegra-6R, 1000 rpm, 5 min) and RNA
was isolated using the RNeasy Micro Kit (Qiagen). Total RNA
(500 ng) was reverse-transcribed using Superscript III Reverse
Transcriptase primed with oligo(dT)12–18 and used as template in
subsequent PCR with Taq DNA Polymerase. List of primers for
amplification of endoderm, ectoderm, and mesoderm markers are
included in Table S1.
Supporting Information
Figure S1 hES H9 cells disassociated by Accutase
improve lentiviral transduction efficiency. Panels A and
C, hES H9 cells treated with Dispase followed by the ROCK
inhibitor Y-27632. Panels B and D, hES H9 cells treated with
Accutase treatment followed by the ROCK inhibitor Y-27632.
Panels A and B show the flow cytometry of GFP
+ cells. Panels C
and D show fluorescence microscopy of individual colonies, 406
magnification.
(TIF)
Figure S2 Expression level of ES H9 cell surface
markers. hES H9 cell surface expression levels were determined
by immunofluorescence staining and measured by flow cytometry.
The mouse IgG anti-SSEA4, anti-CD24, anti-HLA-1 and anti-
CD9 Ab were visualized with anti-mouse IgG PE conjugated
secondary antibody. The rat-IgM anti-SSEA3 was visualized with
anti-Rat IgM-Alexa488 conjugated secondary antibody. An anti-
rat-IgG-FITC conjugated secondary antibody was used for the rat-
IgG anti-FZD7 staining.
(TIF)
Table S1 Table of primers for EB differentiation.
(DOCX)
Text S1 Optimization of gene transduction and expression using
VSV-G pseudotyped lentiviral vectors on the H9 human ES cell
line.
(DOCX)
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